Bryce Weir to Tissue Plasminogen Activator
This is a "connection" page, showing publications Bryce Weir has written about Tissue Plasminogen Activator.
Connection Strength
0.276
-
Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery. 1993 Jun; 32(6):941-7; discussion 947.
Score: 0.101
-
A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery. 1995 Jul; 37(1):168-76; discussion 177-8.
Score: 0.029
-
Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Neurosurgery. 1993 Oct; 33(4):691-6; discussion 696-7.
Score: 0.026
-
Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1991 Aug; 75(2):181-8.
Score: 0.022
-
Lysis of intraventricular hematoma with tissue plasminogen activator. Case report. J Neurosurg. 1991 May; 74(5):803-7.
Score: 0.022
-
The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery. 1990 Feb; 26(2):201-6.
Score: 0.020
-
Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery. 1989 Apr; 24(4):491-8.
Score: 0.019
-
Intrathecal fibrinolytic therapy after subarachnoid hemorrhage: dosage study in a primate model and review of the literature. Can J Neurol Sci. 1989 Feb; 16(1):28-40.
Score: 0.019
-
Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg. 1988 Nov; 69(5):723-35.
Score: 0.018